CDCA2 and hepatocellular carcinoma: In this study, we validated, for the first time, the upregulated expression of CDCA2 in HCC and identified the correlation between higher CDCA2 expression and more advanced clinical stage and tumor grade, Glypican-3 (+), and worse overall survival; these results suggested the worse prognosis of patients with high CDCA2 expression.